drugset / Trial / NCT03783208

Intrauterine G-CSF Administration in RIF

NCT03783208

Completed 157 enrolled Gurgan Clinic
RandomizedParallel-groupOpen-labelSupportive care

Summary

Aim of this study is to investigate the effects of intrauterine G-CSF on endometrial thickness, clinical pregnancy rate and live birth rate in a recurrent implantation failure (RIF) group

Timeline

Start
2018-11-01
Primary completion
2018-12-20
Completion
2018-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic 0.03 iu Other

Indications